ClinicalTrials.gg
TerminatedNCT03993574Updated Nov 19, 2026

Feasibility of a Stroke Specific Self-management Program

An interventional study of Self- management program and Standard care in Stroke and Chronic Conditions, sponsored by The University of Texas Medical Branch, Galveston. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by The University of Texas Medical Branch, Galveston · Not applicable, Interventional, and Other

How we know

Why this study was terminated
Due to the low number of accruals during the Covid 19 environment
Updated Nov 19, 2026Now TerminatedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,995 studies in Stroke with a site in United States — 392 open to participants now, 490 under way, 17 of them phase 3. Stroke · United States.

Enrollment
969th of 1,621
28 · median 40
Started
2019
with 116 others
No phase
1,124 of 1,995
270 open now
Registered
1,183rd of 1,995
by date

Among the 1,995 studies in Stroke with a site in United States, this one is the 969th largest by enrollment of the 1,621 interventional ones that give a count, is one of 117 that started in 2019, is one of 1,124 with no phase, and was the 1,183rd registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

392 of the 1,995 studies in Stroke with a site in United States are open now. Recruiting first, the newest first:

387 more — sign in →

All 392 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,995 studies in Stroke with a site in United States, or all of them as a file.
02

Study summary

Stroke is a leading cause of disability, institutionalization, readmission and death. This research is being completed to accelerate the adoption of evidence-based therapy practices that improve overall stroke care and outcomes. We will implement a feasibility randomized controlled trial (RCT) studying the implementation of a stroke specific chronic disease self-management program. Specifically, if the person is identified to have a chronic vision impairment identified on the vision screen, a specific low vision self-management program will be used. Otherwise the program that will be used is the generic chronic disease self-management program.

Read the detailed description

Approximately 75% of people are living with a prevalent chronic disease like diabetes or hypertension. Despite this high percentage, there is a projected increase of 37% by 2030. There are approximately 795,000 people sustaining a stroke each year, in the United States. Surviving a stroke can cost an estimated $34 billion dollars a year in medical costs and loss of productivity. While there is a sharp decline in mortality rate following stroke, the rate of long-term residual impairments, disabilities and risk for developing high rates of secondary chronic conditions remains high. People living with a new stroke can also have chronic conditions in their past medical histories. Management of prior and new conditions may not become evident until the stroke survivor has returned to the community and are no longer receiving medical services. Additionally, management of chronic conditions, especially for people who now are recovering from a stroke, may require different management plans altogether. The Center for Disease Control and Prevention called for a public health action to address chronic illness. One type of community rehabilitation intervention method is self-management.

Self-management was first developed for well-elderly with chronic diseases. These programs support individuals managing their independently managing symptoms as well as help with the emotional and physical stress associated with chronic disease. Multiple research reports conclude that self-management interventions improve health outcomes, help with management of self-identity and reduce health care costs.

There are existing stroke specific self-management programs, however minimal reported research regarding the best way to implement and measure a stroke specific chronic disease self-management program to optimize health outcomes and improve quality of life. Recently, a qualitative study concluded that any stroke specific self-management program should include 3 conceptual layers to address individual, external and environmental factors essential to enable successful implementation. The first conceptual layer is individual capacity or readiness to respond to the demands to self-management. The second is having external support for self-management. And the third is being in an environment that supports and facilitates success. Another study reported strong feasibility evidence for stroke specific self-management programs versus a standard program for community dwelling stroke survivors. A small study reported a program administered to stroke patients that led to changes in self-efficacy.

Consistent with a feasibility study for implementing evidence based intervention, this project intends to address a need to bridge the translation gap between research evidence and clinical practice. This project intends to provide information to add to existing literature regarding implementation. Thus we plan to use the Determinant Framework, which will help specify determinants which act as barriers and enablers that influence implementation outcomes. Additionally, implementation theories will help us assess the implementation context, as we plan to use a checklist to evaluate factors influencing implementation across different domains (e.g. fidelity). This study also intends to provide preliminary data regarding efficacy in order to determine if a stroke specific program was superior to standard care.

03

Conditions studied

  • Stroke
  • Chronic Conditions
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Acute hospitalization due to diagnosis of stroke
  • at least one chronic medical condition
  • must be able to consent independently
  • be alert and oriented x 3
  • be ≥ 18 years old

Exclusion criteria

Exclusion Criteria:

  • unable to independently consent
  • they do not speak English
  • discharged from acute care to nursing home
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
28 participants (actual)

Study arms

  • Other
    Standard Care

    The standard care group will receive baseline testing #1, standard care, baseline testing #2 and follow up testing approximately 8 weeks later.

    Other: Standard care

  • Experimental
    Experimental

    Experimental group will baseline testing #1, standard care, baseline testing #2 however then participate in a 6-week self-management intervention (either generic or vision specific self-management based) and then get 8 week follow up testing.

    Other: Self- management program

Interventions

  • OtherSelf- management program

    The program sessions are either adapted from the Stanford Patient Education Research Center's program called the Chronic Disease Self-Management Program (CDSMP) or from a vision self-management program. Despite which self-management program, the format for each session will include, review of educational materials (using the CDSMP book/article), discussion via a case vignette (which is always stroke related), and participation in an activity based on that session's topic. These group sessions will be 1.5 hours each week for 6 weeks

  • OtherStandard care

    All stroke patients being discharged from the acute hospital receive the following care: 1. 1 follow-up call within 2 weeks by a nurse coordinator. The call involves checking if medications were able to be filled and how the person is feeling. 2. A stroke clinic appointment that is set to occur 90-days post discharge. 3. A list of their personal medications and generic educational materials. The educational materials are standard forms located in the Epic system. It is the nurses' responsibility to choose what forms to provide, however it is mandatory that stroke risk factor information is included. 4. Information on local support groups. 5. Referrals to start physical, occupational or speech therapy, if recommended by their physician.

06

What researchers measure

Primary outcomes

  1. Feasibility: Patients Screened

    number of patients screened

    Time frame: Collected at baseline 1 (24 hours prior to the patients' discharge from acute care)

  2. Feasibility: Eligible Patients

    number of patients eligible

    Time frame: Collected at baseline 1 (24 hours prior to the patients' discharge from acute care)

  3. Feasibility: Patients Approached

    number of patients approached

    Time frame: Collected at baseline 1 (24 hours prior to the patients' discharge from acute care)

  4. Feasibility: Patients Enrolled

    number of patients enrolled

    Time frame: Collected at baseline 1 (24 hours prior to the patients' discharge from acute care)

  5. Feasibility: Patient Refusals

    number of patient refusals

    Time frame: Collected at follow-up (2 weeks from last day of intervention)

  6. Feasibility: Patient Withdrawals

    number of patient withdrawals

    Time frame: Collected at follow-up (2 weeks from last day of intervention)

Secondary outcomes

  1. Change in self-reported self-management, as measured by the Southampton Stroke Self-Management Questionnaire

    patient-reported outcome measure (PROM) of self-management competency following stroke, likert scale 1-6, higher scores on the scale equal less self-management skills

    Time frame: change in self- management from base line 1 (24 hours prior to discharge from acute care) to base line 2 (3 months)

  2. Change in self-reported self-management, as measured by the Southampton Stroke Self-Management Questionnaire

    patient-reported outcome measure (PROM) of self-management competency following stroke, likert scale 1-6, higher scores on the scale equal less self-management skills

    Time frame: change in self-management from base line 2 (3 months) to follow-up (2 weeks from last day of intervention)

  3. Change in self-reported self-efficacy, as measured by the Patient Reported Outcome Measure Information System (PROMIS) self-efficacy scale

    Self-Efficacy for Managing: Daily Activities, Symptoms, Medications and Treatments, Emotions, and Social Interactions. Likert scale 1-5, higher scores on the scale equal better confidence

    Time frame: change in self-efficacy from base line 1 (24 hours prior to discharge from acute care), base line 2 (3 months)

  4. Change in self-reported self-efficacy, as measured by the Patient Reported Outcome Measure Information System (PROMIS) self-efficacy scale

    Self-Efficacy for Managing: Daily Activities, Symptoms, Medications and Treatments, Emotions, and Social Interactions. Likert scale 1-5, higher scores on the scale equal better confidence

    Time frame: change in self-efficacy from base line 2 (3 months) to follow-up (2 weeks from last day of intervention)

  5. Change in self-reported sleep, as measured by the PROMIS sleep disturbance and sleep-related impairments

    qualitative aspects of sleep and wake function via Likert scale of 1-5, higher scores on the scale equal better sleep

    Time frame: change in sleep from base line 1 (24 hours prior to discharge from acute care), base line 2 (3 months)

  6. Change in self-reported sleep, as measured by the PROMIS sleep disturbance and sleep-related impairments

    qualitative aspects of sleep and wake function via Likert scale of 1-5, higher scores on the scale equal better sleep

    Time frame: change in sleep from base line 2 (3 months) to follow-up (2 weeks from last day of intervention)

  7. Change in self-reported vision, as measured by the national eye institute vision function questionnaire -25

    vision quality of life, likert scale 1-5, higher scores on the scale equal better visual function

    Time frame: change in vision quality of life from base line 1 (24 hours prior to discharge from acute care) to base line 2 (3 months)

  8. Change in self-reported vision, as measured by the national eye institute vision function questionnaire -25

    vision quality of life, likert scale 1-5, higher scores on the scale equal better visual function

    Time frame: change in vision quality of life from base line 2 (3 months) to follow-up (2 weeks from last day of intervention)

Other outcomes

  1. Change in self-reported health distress, as measured by the Health Distress Questionnaire

    health distress, likert scale 0-5, higher scores on the scale equal more distress.

    Time frame: change in health distress from base line 1 (24 hours prior to discharge from acute care) to base line 2 (3 months)

  2. Change in self-reported health distress, as measured by the Health Distress Questionnaire

    health distress, likert scale 0-5, higher scores on the scale equal more distress.

    Time frame: change in health distress from base line 2 (3 months) to follow-up (2 weeks from last day of intervention)

07

Study locations

1 site
  • University of Texas Medical Branch
    Galveston, Texas 77555, United States
08

References and documents

Publications

  • Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. No abstract available. PubMed 28122885 ↗
  • Yang Q, Tong X, Schieb L, Vaughan A, Gillespie C, Wiltz JL, King SC, Odom E, Merritt R, Hong Y, George MG. Vital Signs: Recent Trends in Stroke Death Rates - United States, 2000-2015. MMWR Morb Mortal Wkly Rep. 2017 Sep 8;66(35):933-939. doi: 10.15585/mmwr.mm6635e1. PubMed 28880858 ↗
  • Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011 Mar;38(2):65-76. doi: 10.1007/s10488-010-0319-7. PubMed 20957426 ↗
  • Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009 May;36(5):452-7. doi: 10.1016/j.amepre.2009.02.002. PubMed 19362699 ↗
  • Boger EJ, Hankins M, Demain SH, Latter SM. Development and psychometric evaluation of a new patient -reported outcome measure for stroke self -management: The Southampton Stroke Self - Management Questionnaire (SSSMQ). Health Qual Life Outcomes. 2015 Oct 3;13:165. doi: 10.1186/s12955-015-0349-7. PubMed 26432093 ↗
  • Gruber-Baldini AL, Velozo C, Romero S, Shulman LM. Validation of the PROMIS(R) measures of self-efficacy for managing chronic conditions. Qual Life Res. 2017 Jul;26(7):1915-1924. doi: 10.1007/s11136-017-1527-3. Epub 2017 Feb 26. PubMed 28239781 ↗
  • Buysse DJ, Yu L, Moul DE, Germain A, Stover A, Dodds NE, Johnston KL, Shablesky-Cade MA, Pilkonis PA. Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep. 2010 Jun;33(6):781-92. doi: 10.1093/sleep/33.6.781. PubMed 20550019 ↗
  • Rine RM, Roberts D, Corbin BA, McKean-Cowdin R, Varma R, Beaumont J, Slotkin J, Schubert MC. New portable tool to screen vestibular and visual function--National Institutes of Health Toolbox initiative. J Rehabil Res Dev. 2012;49(2):209-20. doi: 10.1682/jrrd.2010.12.0239. PubMed 22773523 ↗
  • Lorig K, Stewart A, Ritter P, González V, et al. Outcome Measures for Health Education and Other Health Care Interventions. Thousand Oaks, CA, US: Sage Publications, Inc; 1996.
  • Harris JR, Wallace RB. The Institute of Medicine's new report on living well with chronic illness. Prev Chronic Dis. 2012;9:E148. doi: 10.5888/pcd9.120126. No abstract available. PubMed 22995102 ↗
  • Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27;131(4):e29-322. doi: 10.1161/CIR.0000000000000152. Epub 2014 Dec 17. No abstract available. PubMed 25520374 ↗
  • Laver K, Halbert J, Stewart M, Crotty M. Patient readiness and ability to set recovery goals during the first 6 months after stroke. J Allied Health. 2010 Winter;39(4):e149-54. PubMed 21184017 ↗
  • Gallacher K, Morrison D, Jani B, Macdonald S, May CR, Montori VM, Erwin PJ, Batty GD, Eton DT, Langhorne P, Mair FS. Uncovering treatment burden as a key concept for stroke care: a systematic review of qualitative research. PLoS Med. 2013;10(6):e1001473. doi: 10.1371/journal.pmed.1001473. Epub 2013 Jun 25. PubMed 23824703 ↗
  • Allen K, Hazelett S, Jarjoura D, Wright KD, Clough L, Weinhardt J. Improving stroke outcomes: Implementation of a postdischarge care management model. J Clin Outcomes Manag. 2004;11(11):707-714.
  • Smith ML, Ory MG, Ahn S, Kulinski KP, Jiang L, Horel S, Lorig K. National dissemination of chronic disease self-management education programs: an incremental examination of delivery characteristics. Front Public Health. 2015 Apr 27;2:227. doi: 10.3389/fpubh.2014.00227. eCollection 2014. PubMed 25964923 ↗
  • Lorig KR, Ritter P, Stewart AL, Sobel DS, Brown BW Jr, Bandura A, Gonzalez VM, Laurent DD, Holman HR. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care. 2001 Nov;39(11):1217-23. doi: 10.1097/00005650-200111000-00008. PubMed 11606875 ↗
  • Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003 Aug;26(1):1-7. doi: 10.1207/S15324796ABM2601_01. PubMed 12867348 ↗
  • Lorig KR, Sobel DS, Stewart AL, Brown BW Jr, Bandura A, Ritter P, Gonzalez VM, Laurent DD, Holman HR. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care. 1999 Jan;37(1):5-14. doi: 10.1097/00005650-199901000-00003. PubMed 10413387 ↗
  • Jones F, Riazi A. Self-efficacy and self-management after stroke: a systematic review. Disabil Rehabil. 2011;33(10):797-810. doi: 10.3109/09638288.2010.511415. Epub 2010 Aug 27. PubMed 20795919 ↗
  • Kralik D, Koch T, Price K, Howard N. Chronic illness self-management: taking action to create order. J Clin Nurs. 2004 Feb;13(2):259-67. doi: 10.1046/j.1365-2702.2003.00826.x. PubMed 14723679 ↗
  • Ahn S, Basu R, Smith ML, Jiang L, Lorig K, Whitelaw N, Ory MG. The impact of chronic disease self-management programs: healthcare savings through a community-based intervention. BMC Public Health. 2013 Dec 6;13:1141. doi: 10.1186/1471-2458-13-1141. PubMed 24314032 ↗
  • Boger EJ, Demain S, Latter S. Self-management: a systematic review of outcome measures adopted in self-management interventions for stroke. Disabil Rehabil. 2013 Aug;35(17):1415-28. doi: 10.3109/09638288.2012.737080. Epub 2012 Nov 21. PubMed 23167558 ↗
  • Jones F, Mandy A, Partridge C. Changing self-efficacy in individuals following a first time stroke: preliminary study of a novel self-management intervention. Clin Rehabil. 2009 Jun;23(6):522-33. doi: 10.1177/0269215508101749. Epub 2009 Apr 29. PubMed 19403556 ↗
  • Harwood M, Weatherall M, Talemaitoga A, Barber PA, Gommans J, Taylor W, McPherson K, McNaughton H. Taking charge after stroke: promoting self-directed rehabilitation to improve quality of life--a randomized controlled trial. Clin Rehabil. 2012 Jun;26(6):493-501. doi: 10.1177/0269215511426017. Epub 2011 Nov 15. PubMed 22087047 ↗
  • Boger EJ, Demain SH, Latter SM. Stroke self-management: a focus group study to identify the factors influencing self-management following stroke. Int J Nurs Stud. 2015 Jan;52(1):175-87. doi: 10.1016/j.ijnurstu.2014.05.006. Epub 2014 May 24. PubMed 24917370 ↗
  • Battersby M, Hoffmann S, Cadilhac D, Osborne R, Lalor E, Lindley R. 'Getting your life back on track after stroke': a Phase II multi-centered, single-blind, randomized, controlled trial of the Stroke Self-Management Program vs. the Stanford Chronic Condition Self-Management Program or standard care in stroke survivors. Int J Stroke. 2009 Apr;4(2):137-44. doi: 10.1111/j.1747-4949.2009.00261.x. PubMed 19383056 ↗
  • Cadilhac DA, Hoffmann S, Kilkenny M, Lindley R, Lalor E, Osborne RH, Batterbsy M. A phase II multicentered, single-blind, randomized, controlled trial of the stroke self-management program. Stroke. 2011 Jun;42(6):1673-9. doi: 10.1161/STROKEAHA.110.601997. Epub 2011 Apr 14. PubMed 21493910 ↗
  • Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015 Apr 21;10:53. doi: 10.1186/s13012-015-0242-0. PubMed 25895742 ↗
  • Carroll C, Patterson M, Wood S, Booth A, Rick J, Balain S. A conceptual framework for implementation fidelity. Implement Sci. 2007 Nov 30;2:40. doi: 10.1186/1748-5908-2-40. PubMed 18053122 ↗
  • Living a Healthy Life with Chronic Conditions, 4th Edition. https://www.bullpub.com/living-a-healthy-life-with-chronic-conditions-4th-edition.html
  • Rees G, Keeffe JE, Hassell J, Larizza M, Lamoureux E. A self-management program for low vision: program overview and pilot evaluation. Disabil Rehabil. 2010;32(10):808-15. doi: 10.3109/09638280903304193. PubMed 20367406 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Sep 2019 to primary completion in Sep 2021, 24 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: primary completion Dec 2021 → Sep 2021 and completion Dec 2022 → Sep 2021.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 18, 2019
First posted
Jun 20, 2019
StartActual
Sep 3, 2019
Primary completionActual
Sep 17, 2021was Dec 2021
CompletionActual
Sep 17, 2021was Dec 2022
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Terminated Due to the low number of accruals during the Covid 19 environment
changed Nov 19, 2026
Primary completion
Dec 31, 2021→Sep 17, 2021 (actual)
Nov 19, 2026
Study completion
Dec 31, 2022→Sep 17, 2021 (actual)
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Status unknown→Terminated
    Why stopped Due to the low number of accruals during the Covid 19 environment
    Primary completion Dec 31, 2021→Sep 17, 2021 (now actual)
    Study completion Dec 31, 2022→Sep 17, 2021 (now actual)
    + 4 other changes: verification date, references, registry notes and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT03993574
Collaborators
National Center for Advancing Translational Sciences (NCATS), The Claude D. Pepper Older Americans Independence Centers
Responsible party
Sponsor
First posted
Jun 20, 2019
Start date
Sep 3, 2019
Primary completion
Sep 17, 2021
Completion
Sep 17, 2021
Last update
Nov 19, 2026

Study contacts

Timothy Reistetter, PhD
principal investigator · University of Texas

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion